Motus GI Holdings Inc (MOTS)

NASDAQ
1.04
-0.03(-2.80%)
After Hours
1.05
+0.01(+0.962%)
- Real-time Data
  • Volume:
    628,184
  • Bid/Ask:
    1.04/1.05
  • Day's Range:
    1.04 - 1.08

MOTS Overview

Prev. Close
1.07
Day's Range
1.04-1.08
Revenue
120K
Open
1.07
52 wk Range
0.68-2.72
EPS
-0.65
Volume
628,184
Market Cap
48.65M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
3,580,504
P/E Ratio
-
Beta
2.6
1-Year Change
-18.11%
Shares Outstanding
46,779,028
Next Earnings Date
Aug 17, 2021
What is your sentiment on Motus GI Holdings Inc?
or
Market is currently closed. Voting is open during market hours.

Motus GI Holdings Inc News

Motus GI Holdings Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Motus GI Holdings Inc Company Profile

Motus GI Holdings Inc Company Profile

Motus GI Holdings, Inc. is a medical technology company that operates along with its subsidiaries Motus, Ltd. and Motus, Inc. The Company is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure. The Pure-Vu System also helps in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon This device fits standard colonoscopes, allowing the physician to clean poorly-prepped colons in a safe and effective manner to gain clear visualization of the colon mucosa.

Read More
  • Will it rip today?
    0
    • Will the hedger let go of this one?
      0
      • Their device is so awesome it had sales of $36k in Europe last year. With US approval the should get another $36k
        0
        • 36k is how much percentage of their revenue?? any idea?
          1
        • estimate price to sell?
          0
      • Should reach at least $2 with this tech
        0
        • FDA PEOPLE 100% SHOOT TODAY READY TO GO
          0
          • Now it was enough to fall!
            0
            • Damn my limit orders triggered at 1.68. When will it go up and by how much? Why did it drop so bad in Late February?
              0
              • Buy, buy, buy the dip, only buy and hold.
                0
                • This stick is a disaster..... Avoid.
                  2
                  • For me anyway, I am going to keep out of the American Market. Way too volatile and am currently nursing big losses on this share. It had lost 50% value in a week.
                    2
                    • Better to get out after huge gains rather than after huge losses
                      0
                  • to the moon 🚀🌒
                    0
                    • Expected 2.5 soon
                      0
                      • take forever
                        1
                      • are you sure
                        0
                      • Qing Lini think its gona take time
                        1
                    • 1, 550
                      0
                      • to where
                        0
                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.